Applications for Predictive Dissolution Testing

With the discussions and initiatives around real-time release testing, we want to look at how this topic could influence what dissolution testing looks like in the future.

While we certainly cannot avoid dissolution testing entirely, reduced testing could be on the horizon. There are many questions to ask, and we will try to give some guidance on this exciting topic. What are the hurdles; who are the early adopters? Are all products and workflows suitable for this new approach? Do you already have experience with the topic? Then please share it with us and the audience.

Presenter: Karen Krauel-Göllner, PhD (Product Manager Dissolution, Agilent Technologies, Inc.)

Karen Krauel-Göllner is a registered pharmacist and holds a PhD in Pharmacy from the University of Otago, New Zealand. Karen has worked in various roles in the field of pharmaceutical development. For the last 10 years she has been working with Agilent Technologies and currently holds a position as product manager for dissolution systems.

Presenter: Ken Boda (Dissolution Product Specialist, Agilent Technologies, Inc.)

Ken joined Varian (now Agilent) in 2005 as an applications engineer and is now a dissolution product specialist. Prior to working at Agilent, he worked in pharma specializing in dissolution testing and method development. As a dissolution product specialist, Ken works with customers in determining the best systems for their needs and optimizing their workflows. He has also helped educate customers on dissolution science through webinars, the Dissolution Discussion Group, LinkedIn, and other channels.

Presenter: Bryan Crist (President, DissoAssist Consulting, Wilmington, NC, USA)

Bryan has been the president of DissoAssist consulting based in Wilmington, NC, USA since 2021. He provides consulting, coaching, and training services for dissolution and drug release in the pharmaceutical industry. Bryan is also an active member on various USP Expert Committees.

Previously, Bryan was a scientific affairs manager with Agilent Technologies located in Cary, North Carolina, USA. From 1997 to 2021, he focused on providing method and technical application support for dissolution and drug release testing in the pharmaceutical industry as well as working with VanKel, Varian, and eventually Agilent. Prior to 1997, Bryan supervised and managed pharmaceutical laboratories and performed analytical testing with Bristol-Myers Squibb, Merck, AAI, and Abbott Laboratories until he joined the dissolution equipment manufacturer VanKel.

Presenter: Vivian Gray (Founder VA Gray Consulting; Managing Director of Dissolution Technologies)

Vivian has spent the last 40+ years involved in all aspects of dissolution testing and evaluating new dissolution technology. At the United States Pharmacopeia, she enjoyed a long career serving first as a bench chemist, supervisor, and lastly as a liaison to various expert USP committees. In 1997, Vivian joined the DuPont-Merck Pharmaceuticals Company Analytical Research and Development Section as the head of the Dissolution Group. In 2002, she formed her own consulting business, V. A. Gray Consulting, Inc., in dissolution testing and related areas. In June 2003, she became managing director of Dissolution Technologies, a peer-reviewed journal dealing specifically with dissolution testing issues.